About us

The Team

Christopher Prior

CEO

PhD in Biochemistry
Accomplished serial entrepreneur
>30y pharmaceutical executive experience

Aurélien Rizk

CSO

PhD in Computer Science
Co-founder
15 years experience in systems biology.

Jenny Hao

Head of Strategic Partnerships

Senior Executive with strong entrepreneurial spirit.
20 years experience in global pharmaceutical and Medtech companies across Europe, Asia, and the USA.

Luca Zenone

CFO & COO

MSc in Business Administration
Co-founder
Planning, controlling and managing all financial, legal and critical operational activities of the company.

Mirjam Zimmermann

HEAD OF RESEARCH

PhD in Biochemistry
6 years cellular biology, cell signaling and pharmacology.

Yaroslav Nikolaev

HEAD OF COMPUTATIONAL SCIENCE

PhD with dual Biology-MSc Computation-MSc background
12 years research experience in structural and systems biology.

Jens Kurth

HEAD OF DRUG DEVELOPMENT

PhD in Biochemistry
25 years experience driving the development, regulatory approval and commercialization of new drugs.

Susanne Roth

PRINCIPAL SCIENCIST SYSTEMS BIOLOGY

PhD in Systems Biology
6 years GPCR signaling and mathematical modeling.

István Szabó

SENIOR SCIENTIST MACHINE LEARNING IN COMPUTATIONAL CHEMISTRY

PhD in Theoretical and Computational Chemistry
6 years Computational chemistry and Cheminformatics

Tomek Stepniewski

SCIENTIST COMPUTATIONAL CHEMISTRY

PhD in Biomedicine

Agne Tilunaite

SCIENTIST SYSTEM BIOLOGY

PhD in Mathematical Medicine and Biology

Nadine Dobberstein

LABORATORY TECHNICIAN

MSc Quantitative and Systems Biology

Mierelle Schuijt

LABORATORY TECHNICIAN

MSc Biomolecular Sciences

Kylie Pan

PhD STUDENT

MSc Experimental Pharmacology and Therapeutics

Board of Directors

Prof. Dr. Jens Gobrecht

HEAD OF BOARD OF DIRECTORS

Prof. emeritus Laboratory for Micro- and Nanotechnology at the Paul Scherrer Institute (PSI); Co-founder of EULITHA AG; Honorary Member of the Swiss Nanoscience Institute

Dr. Aurélien Rizk

BOARD MEMBER

PhD Computer Science; Co-Founder and CEO InterAx Biotech; Co-Founder Algorizk

Luca Zenone

BOARD MEMBER

MSc ETH Management, Technology and Economics; Engineering and Management Consulting; Co-Founder, CFO and COO InterAx Biotech

Dr. Yiannis Monovoukas

BOARD MEMBER

Managing Partner, Falcon III and SpringTide Ventures Fund I; CEO, Helios Cardiovascular and AuraGen Aesthetics

Dr. Bettina Ernst

BOARD MEMBER

CEO of PRECLIN Biosystems; Board member of multiple biotech companies; VP of Board of Swiss Biotech Association

Scientific Advisors

Prof. Gebhard Schertler

HEAD OF SCIENTIFIC ADVISORY BOARD

Professor for Structural Biology ETH Zürich; Head of Biology and Chemistry at the Paul Scherrer Institute (PSI)

Dr. Chris de Graaf

SCIENTIFIC ADVISOR

Director of Computational Chemistry, Heptares Therapeutics

Prof. Michel Bouvier

SCIENTIFIC ADVISOR

Professor for Biochemistry Université de Montréal; CEO Institute for Research in Immunology and Cancer (IRICoR), Montreal

Dr. Jana Selent

SCIENTIFIC ADVISOR

Associate Professor & Miguel Servet Researcher Research Group on Biomedical Informatics (GRIB)  Hospital del Mar Medical Research Institute (IMIM) DCEXS, Pompeu Fabra University (UPF)

Prof. Ruedi Aebersold

SCIENTIFIC ADVISOR

Pioneer in the field of proteomics and systems biology

Dr. Philipp Berger

SCIENTIFIC ADVISOR

Senior Scientist, Paul Scherrer Institute (PSI)

Prof. Stuart Maudsley

SCIENTIFIC ADVISOR

Odysseus Professor of Receptor Pharmacology at Uni of Antwerpen. He leads a multidisciplinary team to understand the molecular signaling architecture of complex aging-related diseases.

With Support From

Our Story

2010

During his PhD at the Paul Scherrer Institute, Martin Ostermaier plants the "Arrestin" seed of InterAx

2011

During his PostDoc at the Paul Scherrer Institute, Aurßelien Rizk plants the "Systems Biology" seed of InterAx

2014

After his MSc in Management Technology and Economics, Lucas Zenone plants the "Business" seed of InterAx

August 2014

The project receives 150k CHF from the ETH Foundation